Sanofi Gross Profit from 2010 to 2025

SNY Stock

USD 56.90 0.89 1.54%

Sanofi ADR Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 22.5 B in 2025. Gross Profit is the profit Sanofi ADR makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2000-12-31

Previous Quarter

10.1 B

Current Value

5.4 B

Quarterly Volatility

1.9 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 603.9 M or Selling General Administrative of 4.9 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0235 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.

Check out the analysis of Sanofi ADR Correlation against competitors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Sanofi ADR over the last few years. Gross profit is a required income statement account that reflects total revenue of Sanofi ADR minus its cost of goods sold. It is profit before Sanofi ADR operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Sanofi ADR's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 31.09 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Sanofi Gross Profit Regression Statistics

	Arithmetic Mean	24,200,172,581
	Geometric Mean	22,504,157,314
	Coefficient Of Variation	26.35
	Mean Deviation	3,533,305,847
	Median	24,608,000,000
	Standard Deviation	6,377,347,467
	Sample Variance	40670560.7T
	Range	28.1B
	R-Value	0.65
	Mean Square Error	25254132.9T
	R-Squared	0.42
	Significance	0.01
	Slope	868,569,734
	Total Sum of Squares	610058410.7T

Sanofi Gross Profit History

	2025	22.5 B
	2024	31.1 B
	2023	31.8 B
	2022	31.7 B
	2021	26.9 B
	2020	25.2 B
	2019	25.7 B

Other Fundumenentals of Sanofi ADR

Gross Profit Margin

Sanofi ADR Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Retained Earnings	Long Term Debt	Property Plant Equipment	Treasury Stock	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.65	0.86	0.97	0.98	-0.58	0.98	0.89	0.63	0.83	0.81	0.06	0.0	0.59	0.55	0.03	0.53	0.19	-0.53	0.04	0.6	0.58	0.49	-0.11	0.0
Total Stockholder Equity	0.99		0.56	0.87	0.96	0.96	-0.57	0.95	0.89	0.62	0.82	0.8	0.01	0.0	0.53	0.57	0.0	0.55	0.18	-0.5	0.15	0.56	0.53	0.5	-0.08	0.02
Net Debt	0.65	0.56		0.54	0.65	0.67	-0.33	0.76	0.45	0.52	0.67	0.48	0.22	-0.12	0.61	0.26	0.25	0.36	0.1	-0.33	-0.62	0.61	0.55	0.38	-0.41	-0.04
Accounts Payable	0.86	0.87	0.54		0.76	0.81	-0.19	0.83	0.86	0.48	0.71	0.43	-0.33	-0.12	0.32	0.25	0.0	0.78	0.16	-0.65	0.08	0.8	0.74	0.75	-0.18	0.07
Net Receivables	0.97	0.96	0.65	0.76		0.97	-0.67	0.96	0.81	0.63	0.85	0.87	0.17	-0.02	0.64	0.63	0.04	0.4	0.15	-0.39	0.04	0.46	0.43	0.36	-0.12	-0.05
Good Will	0.98	0.96	0.67	0.81	0.97		-0.6	0.97	0.82	0.57	0.8	0.83	0.13	0.0	0.67	0.56	-0.02	0.47	0.29	-0.55	-0.01	0.56	0.53	0.42	-0.2	-0.01
Short Term Investments	-0.58	-0.57	-0.33	-0.19	-0.67	-0.6		-0.57	-0.39	-0.26	-0.41	-0.83	-0.76	-0.2	-0.57	-0.65	0.17	0.31	0.15	0.16	0.0	0.12	0.06	0.26	0.17	0.15
Total Liab	0.98	0.95	0.76	0.83	0.96	0.97	-0.57		0.86	0.63	0.8	0.8	0.13	0.0	0.65	0.5	0.06	0.48	0.2	-0.55	-0.1	0.65	0.62	0.46	-0.14	-0.02
Total Current Assets	0.89	0.89	0.45	0.86	0.81	0.82	-0.39	0.86		0.57	0.57	0.62	-0.08	0.11	0.38	0.35	0.02	0.55	0.18	-0.6	0.23	0.7	0.71	0.5	0.16	0.0
Short Term Debt	0.63	0.62	0.52	0.48	0.63	0.57	-0.26	0.63	0.57		0.59	0.53	-0.02	0.1	0.18	0.31	0.35	0.35	0.14	0.07	-0.04	0.43	0.41	0.43	0.04	0.08
Intangible Assets	0.83	0.82	0.67	0.71	0.85	0.8	-0.41	0.8	0.57	0.59		0.69	-0.1	-0.22	0.44	0.5	0.18	0.6	0.02	-0.2	-0.09	0.45	0.36	0.57	-0.22	0.17
Common Stock	0.81	0.8	0.48	0.43	0.87	0.83	-0.83	0.8	0.62	0.53	0.69		0.41	0.1	0.67	0.73	0.0	0.08	0.11	-0.29	0.03	0.16	0.18	0.13	0.0	0.14
Current Deferred Revenue	0.06	0.01	0.22	-0.33	0.17	0.13	-0.76	0.13	-0.08	-0.02	-0.1	0.41		0.26	0.42	0.31	-0.24	-0.73	-0.13	0.11	-0.28	-0.41	-0.33	-0.71	-0.17	-0.4
Retained Earnings	0.0	0.0	-0.12	-0.12	-0.02	0.0	-0.2	0.0	0.11	0.1	-0.22	0.1	0.26		-0.12	-0.11	0.07	-0.19	0.15	-0.08	0.38	0.02	0.2	-0.24	0.06	-0.11
Long Term Debt	0.59	0.53	0.61	0.32	0.64	0.67	-0.57	0.65	0.38	0.18	0.44	0.67	0.42	-0.12		0.75	0.06	0.08	0.39	-0.47	-0.36	0.18	0.15	0.01	-0.14	-0.13
Property Plant Equipment	0.55	0.57	0.26	0.25	0.63	0.56	-0.65	0.5	0.35	0.31	0.5	0.73	0.31	-0.11	0.75		0.13	0.06	0.15	-0.13	0.1	-0.13	-0.16	-0.03	0.07	-0.06
Treasury Stock	0.03	0.0	0.25	0.0	0.04	-0.02	0.17	0.06	0.02	0.35	0.18	0.0	-0.24	0.07	0.06	0.13		0.27	0.0	0.24	0.01	0.32	0.33	0.24	-0.06	0.11
Deferred Long Term Liab	0.53	0.55	0.36	0.78	0.4	0.47	0.31	0.48	0.55	0.35	0.6	0.08	-0.73	-0.19	0.08	0.06	0.27		0.26	-0.42	0.09	0.74	0.65	0.85	-0.04	0.22
Long Term Investments	0.19	0.18	0.1	0.16	0.15	0.29	0.15	0.2	0.18	0.14	0.02	0.11	-0.13	0.15	0.39	0.15	0.0	0.26		-0.33	0.04	0.2	0.2	0.11	0.11	-0.09
Short Long Term Debt	-0.53	-0.5	-0.33	-0.65	-0.39	-0.55	0.16	-0.55	-0.6	0.07	-0.2	-0.29	0.11	-0.08	-0.47	-0.13	0.24	-0.42	-0.33		0.08	-0.64	-0.65	-0.47	0.14	-0.22
Net Tangible Assets	0.04	0.15	-0.62	0.08	0.04	-0.01	0.0	-0.1	0.23	-0.04	-0.09	0.03	-0.28	0.38	-0.36	0.1	0.01	0.09	0.04	0.08		-0.14	-0.05	-0.06	0.35	-0.08
Long Term Debt Total	0.6	0.56	0.61	0.8	0.46	0.56	0.12	0.65	0.7	0.43	0.45	0.16	-0.41	0.02	0.18	-0.13	0.32	0.74	0.2	-0.64	-0.14		0.98	0.77	-0.19	0.18
Capital Surpluse	0.58	0.53	0.55	0.74	0.43	0.53	0.06	0.62	0.71	0.41	0.36	0.18	-0.33	0.2	0.15	-0.16	0.33	0.65	0.2	-0.65	-0.05	0.98		0.69	-0.15	0.19
Net Invested Capital	0.49	0.5	0.38	0.75	0.36	0.42	0.26	0.46	0.5	0.43	0.57	0.13	-0.71	-0.24	0.01	-0.03	0.24	0.85	0.11	-0.47	-0.06	0.77	0.69		-0.11	0.59
Net Working Capital	-0.11	-0.08	-0.41	-0.18	-0.12	-0.2	0.17	-0.14	0.16	0.04	-0.22	0.0	-0.17	0.06	-0.14	0.07	-0.06	-0.04	0.11	0.14	0.35	-0.19	-0.15	-0.11		0.06
Capital Stock	0.0	0.02	-0.04	0.07	-0.05	-0.01	0.15	-0.02	0.0	0.08	0.17	0.14	-0.4	-0.11	-0.13	-0.06	0.11	0.22	-0.09	-0.22	-0.08	0.18	0.19	0.59	0.06

Click cells to compare fundamentals

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	31.1 B	22.5 B
Gross Profit Margin	0.70	0.79

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC